Glioblastoma Multiforme: Molecular Biology and Updated Systematic Review on Natural Extract and Phytochemical Efficacy In-vitro

References (134)

1. 1 Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma [DOI]
2. 2 Comprehensive genomic characterization defines human glioblastoma genes and core pathways [DOI]
3. 3 AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 [DOI]
4. 4 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [DOI]
5. 5 Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation [DOI]
6. 6 The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth [DOI]
7. 7 Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics [DOI]
8. 8 ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase [DOI]
9. 9 Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis [DOI]
10. 10 ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect [DOI]
11. 11 Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice [DOI]
12. 12 The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype [DOI]
13. 13 The role of hypoxia-inducible factors in tumorigenesis [DOI]
14. 14 Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation [DOI]
15. 15 Apaf-1 is a transcriptional target for E2F and p53 [DOI]
16. 16 Autophagy and apoptosis: where do they meet? [DOI]
17. 17 Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein [DOI]
18. 18 Somatic mutations of PTEN in glioblastoma multiforme.
19. 19 Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review [DOI]
20. 20 Endoplasmic Reticulum Stress and Cancer [DOI]
21. 21 Cell death by autophagy: facts and apparent artefacts [DOI]
22. 22 New aspects of the Warburg effect in cancer cell biology [DOI]
23. 23 The Autophagy Protein Atg12 Associates with Antiapoptotic Bcl-2 Family Members to Promote Mitochondrial Apoptosis [DOI]
24. 24 The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells [DOI]
25. 25 Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology [DOI]
26. 26 Multiple roles of the cytoskeleton in autophagy [DOI]
27. 27 Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers [DOI]
28. 28 Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies [DOI]
29. 29 Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding [DOI]
30. 30 Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery [DOI]
31. 31 Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect [DOI]
32. 32 BCL-2 Family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy [DOI]
33. 33 Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic Implications [DOI]
34. 34 DAP-kinase and autophagy [DOI]
35. 35 Uncovering Therapeutic Targets FOR Glioblastoma: A Systems Biology Approach [DOI]
36. 36 Identification of survival‐related genes of the phosphatidylinositol 3′‐kinase signaling pathway in glioblastoma multiforme [DOI]
37. 37 Inhibition of PI3K-Akt-mTOR Signaling in Glioblastoma by mTORC1/2 Inhibitors [DOI]
38. 38 Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? [DOI]
39. 39 Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells [DOI]
40. 40 Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo [DOI]
41. 41 Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach [DOI]
42. 42 Antineoplastic effects of deoxypodophyllotoxin, a potent cytotoxic agent of plant origin, on glioblastoma U-87 MG and SF126 cells [DOI]
43. 43 Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination [DOI]
44. 44 Impact of nuclear factor erythroid-derived 2–like 2 and p62/sequestosome expression on prognosis of patients with gliomas [DOI]
45. 45 Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme [DOI]
46. 46 Antitumour Efficacy of Piper tuberculatum and Piplartine Based on the Hollow Fiber Assay [DOI]
47. 47 NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells [DOI]
48. 48 Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells [DOI]
49. 49 Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system.
50. 50 NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development [DOI]
51. 51 The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [DOI]
52. 52 Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 [DOI]
53. 53 The Somatic Genomic Landscape of Glioblastoma [DOI]
54. 54 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis [DOI]
55. 55 A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma [DOI]
56. 56 Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma [DOI]
57. 57 ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery [DOI]
58. 58 Targeting mitochondria for cancer therapy [DOI]
59. 59 The Roles of Autophagy in Cancer [DOI]
60. 60 PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma [DOI]
61. 61 Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review [DOI]
62. 62 Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction [DOI]
63. 63 Anti- and pro-tumor functions of autophagy [DOI]
64. 64 Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2 [DOI]
65. 65 Targeting cellular pathways in glioblastoma multiforme [DOI]
66. 66 Ten-year survival in glioblastoma. A systematic review [DOI]
67. 67 Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions [DOI]
68. 68 Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics [DOI]
69. 69 Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells [DOI]
70. 70 Hallmarks of glioblastoma: a systematic review [DOI]
71. 71 Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities [DOI]
72. 72 Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism [DOI]
73. 73 Identification of a functional antioxidant response element at the HIF1A locus [DOI]
74. 74 Molecular classification of gliomas [DOI]
75. 75 Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells [DOI]
76. 76 The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma [DOI]
77. 77 Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications [DOI]
78. 78 ATG4B (Autophagin-1) Phosphorylation Modulates Autophagy [DOI]
79. 79 An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme—Role in Pathogenesis and Therapeutic Perspective [DOI]
80. 80 Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds [DOI]
81. 81 Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma [DOI]
82. 82 Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma [DOI]
83. 83 PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors [DOI]
84. 84 Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes [DOI]
85. 85 Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy [DOI]
86. 86 Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation [DOI]
87. 87 Beclin 1-Vps34 complex architecture: Understanding the nuts and bolts of therapeutic targets [DOI]
88. 88 Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging [DOI]
89. 89 The VPS34 PI3K negatively regulates RAB-5 during endosome maturation [DOI]
90. 90 The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells [DOI]
91. 91 Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor [DOI]
92. 92 Cytotoxic effects of gastrodin extracted from the rhizome of Gastrodia elata Blume in glioblastoma cells, but not in normal astrocytes, via the induction of oxidative stress-associated apoptosis that involved cell cycle arrest and p53 activation [DOI]
93. 93 Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion [DOI]
94. 94 Gossypol enhances radiation-induced autophagy in glioblastoma multiforme [DOI]
95. 95 Celastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro [DOI]
96. 96 Down-regulation of CHERP inhibits neuroblastoma cell proliferation and induces apoptosis through ER stress induction [DOI]
97. 97 Fatty Acids Rich Extract From Clerodendrum volubile Suppresses Cell Migration; Abates Oxidative Stress; and Regulates Cell Cycle Progression in Glioblastoma Multiforme (U87 MG) Cells [DOI]
98. 98 Fabrication of plumbagin on silver nanoframework for tunable redox modulation: Implications for therapeutic angiogenesis [DOI]
99. 99 Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism [DOI]
100. 100 Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma [DOI]
101. 101 The 2021 WHO Classification of Tumors of the Central Nervous System: a summary [DOI]
102. 102 Epidemiology of Glioblastoma Multiforme–Literature Review [DOI]
103. 103 Current FDA-Approved Therapies for High-Grade Malignant Gliomas [DOI]
104. 104 Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population [DOI]
105. 105 Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress [DOI]
106. 106 Glioblastoma Treatment Modalities besides Surgery [DOI]
107. 107 Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect [DOI]
108. 108 Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis [DOI]
109. 109 Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme [DOI]
110. 110 How we treat glioblastoma [DOI]
111. 111 Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy [DOI]
112. 112 Roles of Non-coding RNAs and Angiogenesis in Glioblastoma [DOI]
113. 113 The incidence of major subtypes of primary brain tumors in adults in England 1995-2017 [DOI]
114. 114 Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors [DOI]
115. 115 Challenging the indiscriminate use of temozolomide in pediatric high‐grade gliomas: A review of past, current, and emerging therapies [DOI]
116. 116 Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux [DOI]
117. 117 Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature [DOI]
118. 118 Bacoside A Induced Sub-G0 Arrest and Early Apoptosis in Human Glioblastoma Cell Line U-87 MG through Notch Signaling Pathway [DOI]
119. 119 Clinicopathological Significance of Autophagy-related Proteins and its Association With Genetic Alterations in Gliomas [DOI]
120. 120 Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro [DOI]
121. 121 Cedrol, a Sesquiterpene Alcohol, Enhances the Anticancer Efficacy of Temozolomide in Attenuating Drug Resistance via Regulation of the DNA Damage Response and MGMT Expression [DOI]
122. 122 A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells [DOI]
123. 123 Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms [DOI]
124. 124 The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties [DOI]
125. 125 Endoplasmic reticulum stress‑induced cell death as a potential mechanism for targeted therapy in glioblastoma (Review) [DOI]
126. 126 Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System [DOI]
127. 127 An In Vitro Study of Saffron Carotenoids: The Effect of Crocin Extracts and Dimethylcrocetin on Cancer Cell Lines [DOI]
128. 128 Molecular Biology in Glioblastoma Multiforme Treatment [DOI]
129. 129 Hypoxic Roadmap of Glioblastoma—Learning about Directions and Distances in the Brain Tumor Environment [DOI]
130. 130 Phlomis fruticosa l. exerts in vitro antineurodegenerative and antioxidant activities and induces prooxidant effect in glioblastoma cell line [DOI]
131. 131 Inhibiting effect of p-Coumaric acid on U87MG human glioblastoma cell growth [DOI]
132. 132 Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma [DOI]
133. 133 Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an In Vitro Glioblastoma Model [DOI]
134. 134 A neglected natural source for targeting glioblastoma [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Antibacterial Activity of Bidens pilosa Extracts on Escherichia coli O157: H7 Isolated from Apparently Healthy Individuals — shares topic coverage
• Antimicrobial Activity, Phytochemical Screening and Nutrient Analysis of Tetrapleura tetraptera and Piper guineense — shares topic coverage
• Phytochemical and Nutraceutical Potentials of Beach Bean (Canavalia rosea SW.) DC Grown in Anyigba, Kogi State, Nigeria — shares topic coverage
• Phytochemical Screening, In vitro Antioxidant Capacity and Nephro-protective Effects of Combined Extract of Psidium guajava and Carica papaya Leaves in Rats Intoxicated with Cadmium — shares topic coverage
• Therapeutic Potential of Phytochemicals in Autoimmune Diseases: A Systematic Review — shares topic coverage